Period Ending | Jan 31, 2013 | Feb 2, 2012 | Jan 27, 2011 |
---|
Total Revenue
|
56,940,000
|
62,071,000
|
61,494,000
| Cost of Revenue | 44,754,000 | 48,260,000 | 50,098,000 | |
Gross Profit
|
12,186,000
|
13,811,000
|
11,396,000
| |
|
Operating Expenses |
|
Research Development | 1,072,000 | 856,000 | 661,000 |
|
Selling General and Administrative | 8,102,000 | 8,524,000 | 7,302,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
3,012,000
|
4,431,000
|
3,433,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 3,012,000 | 4,431,000 | 3,433,000 |
|
Interest Expense | 171,000 | 191,000 | 83,000 |
|
Income Before Tax | 2,841,000 | 4,240,000 | 3,350,000 |
|
Income Tax Expense | 469,000 | 748,000 | 715,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 2,372,000 | 3,492,000 | 2,635,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
2,372,000
|
3,492,000
|
2,635,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
2,372,000
|
3,492,000
|
2,635,000
|
|